IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.
Klingbeil KD, Tang JP, Graham DS, Lofftus SY, Jaiswal AK, Lin TL, Frias C, Chen LY, Nakasaki M, Dry SM, Crompton JG, Eilber FC, Rao DS, Kalbasi A, Kadera BE.
Klingbeil KD, et al. Among authors: jaiswal ak.
Cancers (Basel). 2023 Sep 9;15(18):4489. doi: 10.3390/cancers15184489.
Cancers (Basel). 2023.
PMID: 37760460
Free PMC article.